(Q24244802)

1

0 references

Jonathan C Ipser

2

0 references

Carli Sager

4

0 references

Taryn Amos

Cochrane Database of Systematic Reviews

5

0 references

language of work or name

English

0 references

publication date

25 January 2006

0 references

published in

0 references

issue

1

0 references

page(s)

CD002795

0 references

cites work

Predictors of treatment response in patients with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Characterizing the effects of sertraline in post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Tolerability of fluoxetine in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Inositol treatment of post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A controlled trial of phenelzine in posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Low-dose cortisol for symptoms of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Posttraumatic stress disorder and sleep difficulty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A randomized effectiveness trial of stepped collaborative care for acutely injured trauma survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Psychopharmacological treatment in PTSD: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Confidence intervals for the number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Quantitative analysis of sponsorship bias in economic studies of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Measuring the quality of trials: the quality of quality scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Psychological treatment of post-traumatic stress disorder (PTSD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A multidimensional meta-analysis of psychotherapy for PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Traumatic events and posttraumatic stress disorder in an urban population of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

MRI reveals gross structural abnormalities in PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Bupropion treatment in veterans with posttraumatic stress disorder: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Psychobiologic mechanisms of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Psychometric properties of the Impact of Event Scale - Revised.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Treatment for posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A Pilot Study of Phenelzine in the Treatment of Post-traumatic Stress Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Drug therapy of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Assessment of a new self-rating scale for post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Fluvoxamine treatment for chronic PTSD: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Publication bias in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Lithium for irritability in post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Toward rational pharmacotherapy for posttraumatic stress disorder: an interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Clozapine treatment for a veteran with comorbid psychosis and PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Cognitive behaviour therapy for posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Using numerical results from systematic reviews in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Pilot evaluation of hypnotic medication during acute traumatic stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Olanzapine treatment for post-traumatic stress disorder: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Brief early psychological interventions following trauma: a systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Psychological debriefing for preventing post traumatic stress disorder (PTSD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Sertraline in the treatment of rape victims with posttraumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Full publication of results initially presented in abstracts. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

An open trial of citalopram in adolescents with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Treatment of posttraumatic stress disorder: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Fluoxetine reduces explosiveness and elevates mood of vietnam combat vets with PTSD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Efficacy of treatments for posttraumatic stress disorder. An empirical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Posttraumatic stress disorder and partial complex seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Why sources of heterogeneity in meta-analysis should be investigated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

The drug treatment of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Posttraumatic stress disorder in vietnam veterans clinical and EEG findings; possible therapeutic effects of carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Conflict between current knowledge about posttraumatic stress disorder and its original conceptual basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Rapid Response to Buspirone in a Case of Post-Traumatic Stress Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Pharmacologic Treatment of Veterans With Posttraumatic Stress Disorder and Concomitant Affective Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

Diagnostic and psychopharmacological treatment characteristics of 536 inpatients with posttraumatic stress disorder.

21 January 2018

1 reference

12 December 2020

Antidepressant treatment of posttraumatic stress disorder and major depression in veterans

1 reference

12 December 2020

Effects of the benzodiazepine antagonist flumazenil in PTSD

1 reference

12 December 2020

Treatment of post-traumatic stress disorder with imipramine

1 reference

12 December 2020

Behavioral family therapy for Vietnam combat veterans with posttraumatic stress disorder

1 reference

12 December 2020

Antidepressant treatment, posttraumatic stress disorder, survivor guilt, and spiritual awakening.

1 reference

12 December 2020

Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence

1 reference

12 December 2020

Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans

1 reference

12 December 2020

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment

1 reference

12 December 2020

Use of thioridazine in post-traumatic stress disorder

1 reference

12 December 2020

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

1 reference

12 December 2020

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

12 December 2020

An open trial of fluoxetine in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Treatment of posttraumatic stress disorder with nefazodone.

1 reference

12 December 2020

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

12 December 2020

Pilot program of treatment for PTSD

1 reference

12 December 2020

Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder.

1 reference

12 December 2020

Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder.

1 reference

12 December 2020

The obsessive quality and clomipramine treatment in PTSD

1 reference

12 December 2020

Trauma: prevalence, impairment, service use, and cost.

1 reference

12 December 2020

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

12 December 2020

Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder

1 reference

12 December 2020

Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder

1 reference

12 December 2020

A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance.

1 reference

12 December 2020

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

1 reference

12 December 2020

Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment

1 reference

12 December 2020

A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women.

1 reference

12 December 2020

Serotonergic agents in the management of dementia and posttraumatic stress disorder

1 reference

12 December 2020

Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety

1 reference

12 December 2020

Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety

1 reference

12 December 2020

Low dose lithium carbonate in the treatment of post traumatic stress disorder: brief communication.

1 reference

12 December 2020

Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment

1 reference

12 December 2020

A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults

1 reference

12 December 2020

The use of anticonvulsants in posttraumatic stress disorder: case study and overview

1 reference

12 December 2020

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

12 December 2020

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

12 December 2020

Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder

1 reference

12 December 2020

Psychopharmacology. Psychopharmacological issues in posttraumatic stress disorder.

1 reference

12 December 2020

A pilot study of mirtazapine in post-traumatic stress disorder

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders

1 reference

12 December 2020

Nefazodone in post-traumatic stress disorder: results from six open-label trials

1 reference

12 December 2020

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial

1 reference

12 December 2020

Neuroimaging findings in post-traumatic stress disorder. Systematic review

1 reference

12 December 2020

Tricyclics: possible treatment for posttraumatic stress disorder.

1 reference

12 December 2020

Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design

1 reference

12 December 2020

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

12 December 2020

Divalproex in posttraumatic stress disorder

1 reference

12 December 2020

Carbamazepine for PTSD

1 reference

12 December 2020

Trazodone for the treatment of anxiety symptoms in substance abusers.

1 reference

12 December 2020

Tiagabine for posttraumatic stress disorder: a case series of 7 women.

1 reference

12 December 2020

Assessment and treatment of torture victims: a critical review

1 reference

12 December 2020

Placebo effect in posttraumatic stress disorders

1 reference

12 December 2020

A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder.

1 reference

12 December 2020

beta-Adrenergic blockade and emotional memory in PTSD.

1 reference

12 December 2020

Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder.

1 reference

12 December 2020

Biological therapies for posttraumatic stress disorder: an overview.

1 reference

12 December 2020

Noradrenergic and serotonergic function in posttraumatic stress disorder

1 reference

12 December 2020

Clonidine in Cambodian patients with posttraumatic stress disorder

1 reference

12 December 2020

Medication compliance, antidepressant blood levels, and side effects in Southeast Asian patients.

1 reference

12 December 2020

Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome.

1 reference

12 December 2020

Hypnotic medication in the aftermath of trauma

1 reference

12 December 2020

Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: a pilot study

1 reference

12 December 2020

Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder

1 reference

12 December 2020

Response characteristics to antidepressants and placebo in post-traumatic stress disorder

1 reference

12 December 2020

Monoamine oxidase inhibitors in posttraumatic stress disorder. Promise and problems in Indochinese survivors of trauma.

1 reference

12 December 2020

Impact of Event Scale: A Measure of Subjective Stress

1 reference

12 December 2020

Brief psychotherapy for posttraumatic stress disorders.

1 reference

12 December 2020

The promise and problems of meta-analysis

1 reference

12 December 2020

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

12 December 2020

Valproate in combat-related posttraumatic stress disorder.

1 reference

12 December 2020

A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake

1 reference

12 December 2020

An open trial of moclobemide in the treatment of post-traumatic stress disorder

1 reference

12 December 2020

The measurement of disability.

1 reference

12 December 2020

Guanfacine for PTSD nightmares

1 reference

12 December 2020

Fluoxetine in posttraumatic stress disorder

1 reference

12 December 2020

Open trial of nefazodone for combat-related posttraumatic stress disorder

1 reference

12 December 2020

Buspirone in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Clonidine for posttraumatic stress disorder in preschool children

1 reference

12 December 2020

Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies

1 reference

12 December 2020

Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.

1 reference

12 December 2020

Open prospective trial of fluoxetine for posttraumatic stress disorder.

1 reference

12 December 2020

[Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability]

1 reference

12 December 2020

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

1 reference

12 December 2020

Factor analysis of treatment response in posttraumatic stress disorder

1 reference

12 December 2020

Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

1 reference

12 December 2020

New approaches in the pharmacotherapy of posttraumatic stress disorder.

1 reference

12 December 2020

Treatment of recent trauma survivors with benzodiazepines: a prospective study.

1 reference

12 December 2020

Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo

1 reference

12 December 2020

Categorizing fear: the role of trauma in a clinical formulation.

1 reference

12 December 2020

Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions

1 reference

12 December 2020

Fluvoxamine in civilians with posttraumatic stress disorder

1 reference

12 December 2020

Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder

1 reference

12 December 2020

The interaction between pharmacotherapy and psychotherapy in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

A comparison of handsearching versus MEDLINE searching to identify reports of randomized controlled trials

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of traumatic war neurosis with phenelzine

1 reference

12 December 2020

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

12 December 2020

Effects of psychotherapeutic treatments for PTSD: a meta-analysis of controlled clinical trials

1 reference

12 December 2020

Predicting response to amitriptyline in posttraumatic stress disorder

1 reference

12 December 2020

Buspirone potentiation of antidepressants in the treatment of PTSD

1 reference

12 December 2020

Posttraumatic stress disorder

1 reference

12 December 2020

Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002795.PUB2

7 January 2021